150
Participants
Start Date
June 9, 2020
Primary Completion Date
July 31, 2023
Study Completion Date
June 28, 2024
Paclitaxel
Commercially available paclitaxel for IV administration will be obtained by clinical sites in US.
Afuresertib
"Each afuresertib 50 mg tablet, intended for oral administration, contains afuresertib (hydrochloride salt) equivalent to 50 mg of afuresertib (free base).~Each afuresertib 75 mg tablet, intended for oral administration, contains afuresertib (hydrochloride salt) equivalent to 75 mg of afuresertib (free base)"
Montefiore Medical Center, The Bronx
Abington Memorial Hospital, Willow Grove
Thomas Jefferson University, Philadelphia
Virginia Oncology Associates, Norfolk
University of Cincinnati Medical Center, Cincinnati
OHCare Oncology Hematology Care (OHC), Inc. - Kenwood Office, Cincinnati
University of Chicago, Chicago
Nebraska Methodist Hospital, Omaha
Women's Cancer Care, Covington
Highlands Oncology Group, Rogers
USO Texas Oncology, Longview
Texas Oncology, Fort Worth
Baylor Scott & White Medical Center, Temple
Houston Methodist Hospital, Houston
University of Texas Health Science Center at Houston, Houston
Texas Oncology, The Woodlands
US Texas Oncology, San Antonio
Texas Oncology, Austin
Rocky Mountain Cancer Centers, Littleton
Arizona Oncology Associates, Phoenix
Arizona Oncology, Tucson
Southwest Women's Oncology Group, Albuquerque
Gynecology Oncology Associates Newport Beach, Newport Beach
Kapiolani Medical Center for Women and Children, Honolulu
University of Washington/Seattle Cancer Care Alliance, Seattle
Tufts Medical Center, Boston
University of Massachusetts, Worcester
MD Anderson Cancer Center at Cooper, Camden
Holy Name Medical Center, Teaneck
Women & Infants Hospital of Rhode Island, Providence
Beijing Obstetrics & Gynecology Hospital, Capital Medical University, Beijing
Cancer Hospital Chinese Academy of Medical Sciences, Beijing
Peking University Cancer Hospital, Beijing
Chongqing University Cancer Hospital, Chongqing
Sun Yat-sen University Cancer Center, Guangdong
Harbin Medical University Cancer Hospital, Heilongjiang
Henan Cancer Hospital, Henan
Hubei Cancer Hospital, Hubei
Hunan Cancer Hospital, Hunan
Jilin Cancer Hospital, Jilin
Liaoning Cancer Hospital, Liaoyang
Qilu Hospital of Shandong University, Shandong
Obstetrics & Gynecology Hospital of Fudan University, Shanghai
Zhongshan Hospital affiliated to Fudan University, Shanghai
West China Second University Hospital,Sichuan University, Sichuan
The Second Hospital of Tianjin Medical University, Tianjin
Women's Hospital school of medicine Zhejiang University, Zhejiang
Laekna Limited
INDUSTRY